RELESTAT gtt opht 0.05 % fl 5 ml
7680563100015
CH-56310
S01GX
11.06.2.
1 / 3
google
Details
- Product number
- 5631001
- CPT
- -
- Packaging group
- 5
- Unit
- ml
- Composition
- epinastinum hydrochloridum 0.5 mg, natrii dihydrogenophosphas dihydricus 7.8 mg, natrii chloridum, dinatrii edetas, benzalkonii chloridum 0.1 mg, acidum hydrochloridum aut natrii hydroxidum, aqua purificata, ad solutionem pro 1 ml.
Articles (1)
Relestat, Augentropfen
Augentropfen
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
7.8 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.1 MG | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 17.65
Specialties list
Yes
Generic
No
SL addition date:
01/02/2005
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 56310
- Drug name
- Relestat, Augentropfen
- Galenic form
- AUGT
- ATC Code
- S01GX
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 07/12/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 11.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RELESTAT gtt opht 0.05 % fl 5 ml
- Description (DE)
- RELESTAT Gtt Opht 0.05 % Fl 5 ml
- Market launch
- 07/12/2004
- Narcotic (BTM)
- No